Goldman Sachs’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.59M Sell
143,702
-25,685
-15% -$1.54M ﹤0.01% 2378
2025
Q1
$8.89M Buy
169,387
+1,821
+1% +$95.6K ﹤0.01% 2315
2024
Q4
$9.22M Buy
167,566
+10,617
+7% +$584K ﹤0.01% 2396
2024
Q3
$7.89M Buy
156,949
+77,956
+99% +$3.92M ﹤0.01% 2434
2024
Q2
$3.47M Buy
78,993
+45,712
+137% +$2.01M ﹤0.01% 2870
2024
Q1
$1.46M Sell
33,281
-20,802
-38% -$915K ﹤0.01% 3377
2023
Q4
$2.57M Sell
54,083
-1,993
-4% -$94.6K ﹤0.01% 3054
2023
Q3
$2.49M Buy
56,076
+9,109
+19% +$404K ﹤0.01% 2963
2023
Q2
$2.24M Sell
46,967
-1,638
-3% -$78.2K ﹤0.01% 3134
2023
Q1
$1.91M Sell
48,605
-6,645
-12% -$261K ﹤0.01% 3245
2022
Q4
$1.56M Buy
55,250
+9,184
+20% +$260K ﹤0.01% 3426
2022
Q3
$1.39M Buy
46,066
+8,643
+23% +$260K ﹤0.01% 3626
2022
Q2
$1.27M Buy
37,423
+2,918
+8% +$99K ﹤0.01% 3779
2022
Q1
$1.55M Buy
34,505
+20,265
+142% +$909K ﹤0.01% 3761
2021
Q4
$659K Sell
14,240
-231
-2% -$10.7K ﹤0.01% 4338
2021
Q3
$486K Buy
14,471
+7,326
+103% +$246K ﹤0.01% 4403
2021
Q2
$210K Buy
+7,145
New +$210K ﹤0.01% 4894
2019
Q2
Sell
-9,344
Closed -$262K 4228
2019
Q1
$262K Sell
9,344
-3,019
-24% -$84.7K ﹤0.01% 3787
2018
Q4
$302K Buy
12,363
+2,433
+25% +$59.4K ﹤0.01% 3603
2018
Q3
$369K Sell
9,930
-1,971
-17% -$73.2K ﹤0.01% 3574
2018
Q2
$247K Buy
+11,901
New +$247K ﹤0.01% 3799
2017
Q2
Sell
-32,619
Closed -$290K 4455
2017
Q1
$290K Buy
+32,619
New +$290K ﹤0.01% 3797
2015
Q4
Sell
-9,263
Closed -$226K 4529
2015
Q3
$226K Sell
9,263
-3,322
-26% -$81.1K ﹤0.01% 3793
2015
Q2
$293K Sell
12,585
-2,819
-18% -$65.6K ﹤0.01% 3728
2015
Q1
$235K Buy
15,404
+1
+0% +$15 ﹤0.01% 3790
2014
Q4
$199K Sell
15,403
-4,703
-23% -$60.8K ﹤0.01% 3972
2014
Q3
$141K Buy
+20,106
New +$141K ﹤0.01% 4116